ARTICLES BY MAIK JORNITZ
-
![Microbiology laboratory work-GettyImages-1483940532]( "Rising Allure And Critical Considerations Of Point-Of-Care Processing")
Rising Allure And Critical Considerations Of Point-Of-Care Processing8/1/2024Mobile and standard cleanroom infrastructures are becoming more popular to meet the logistical demands of personalized medicine and public health emergencies.
-
![GettyImages-1418152314]( "Unpacking The Importance Of Lipid Nanoparticle Production Platforms")
Unpacking The Importance Of Lipid Nanoparticle Production Platforms4/15/2024Batch processing platforms for LNPs lack efficiency, appropriate controls, and yield optimization. Continuous manufacturing platforms may address some of those issues.
-
![Drug-Manufacturing-GettyImages-1424064172]( "Is Your Bioprocess Facility Truly 'State-Of-The-Art?'")
Is Your Bioprocess Facility Truly 'State-Of-The-Art?'12/6/2023Biopharmaceutical companies calling their facilities "state-of-the-art" should use the latest, most cutting-edge technologies and techniques. Many say they do that but don't really.
-
![GettyImages-1418151701]( "Navigating The Pros And Cons In Annex 1's PUPSIT Requirements")
Navigating The Pros And Cons In Annex 1's PUPSIT Requirements7/12/2023Annex 1 made Pre-use Post Sterilization Integrity Testing, or PUPSIT, a requirement, and enforcement has begun in earnest over the last few years. This article digs into the problems that downstream filter manipulation can cause and questions whether the risks outweigh any benefits.
Maik Jornitz
Maik W. Jornitz is a technical expert with over 35 years of experience in bioprocesses, especially sterilizing grade filtration and single-use technologies, including regulatory requirements, integrity testing, systems design, and optimization. Jornitz has published 11 books, 18 book chapters, and more than 100 scientific papers. He is a member of multiple PDA Task Forces, a former chair of the PDA Board of Directors, and the PDA’s Science Advisory Board.